Evaluation of aerosolized epoprostenol for hypoxemia in non-intubated patients with coronavirus disease 2019.

Vivek K KatariaKlayton RymanGinger Tsai-NguyenYosafe WakwayaAriel Modrykamien

Published in: Hospital practice (1995) (2022)

The utilization of aEPO in COVID-19 patients treated with HFNC is not associated with a reduction in the rate of mechanical ventilation. Nevertheless, the application of this strategy may prolong the time to invasive mechanical ventilation, without affecting other clinical outcomes.

Keyphrases

mechanical ventilation
coronavirus disease
acute respiratory distress syndrome
intensive care unit
respiratory failure
respiratory syndrome coronavirus
sars cov
extracorporeal membrane oxygenation